Compare $ALGS vs $GRDX | Chartloom

Compare

$ALGS vs $GRDX

Aligos Therapeutics Inc · GridAI Technologies Corp

ALGS

Aligos Therapeutics Inc

GRDX

GridAI Technologies Corp

Compare $ALGS vs $GRDX

Comparing Aligos Therapeutics Inc and GridAI Technologies Corp

ALGSAligos Therapeutics Inc

GRDXGridAI Technologies Corp

ALGSAligos Therapeutics Inc

Market cap

$33M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.83x

Rev growth (TTM)

893.0%

YTD performance

-41.5%

52W performance

-46.2%

FCF yield

-286.0%

GRDXGridAI Technologies Corp

Market cap

$34M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-3.3%

52W performance

24.2%

FCF yield

-24.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALGS

GRDX

Detailed metrics comparison

ALGS

Aligos Therapeutics Inc

GRDX

GridAI Technologies Corp

Market Cap

ALGS$33M

GRDX$34M

Enterprise Value

ALGS$3M

GRDX$34M

Price

ALGS$5.34

GRDX$4.97

P/E Ratio

ALGSN/A

GRDXN/A

P/S Ratio

ALGS1.05x

GRDX209.46x

EV/Sales

ALGS0.09x

GRDX211.31x

EV/EBITDA

ALGS0.00x

GRDX0.00x

P/B Ratio

ALGS1.09x

GRDX1.94x

P/FCF Ratio

ALGSN/A

GRDXN/A

EV/FCF

ALGS-0.03x

GRDX-4.17x

PEG Ratio

ALGSN/A

GRDXN/A

Forward P/E (NTM)

ALGSN/A

GRDXN/A

Forward P/S (NTM)

ALGS4.83x

GRDXN/A

Revenue (TTM)

ALGS$32M

GRDX$160K

Revenue Growth (YoY)

ALGS893.0%

GRDXN/A

Forward Rev Growth

ALGS-84.9%

GRDX0.0%

Gross Margin (TTM)

ALGS0.0%

GRDX-815.2%

Operating Margin (TTM)

ALGS0.0%

GRDX0.0%

EBITDA Margin (TTM)

ALGS-247.2%

GRDX-6577.4%

Net Margin (TTM)

ALGS-241.0%

GRDX-12994.7%

FCF Margin (TTM)

ALGS-299.9%

GRDX-5062.9%

Net Income (TTM)

ALGS$-76M

GRDX$-21M

FCF (TTM)

ALGS$-95M

GRDX$-8M

EPS (TTM)

ALGS-$7.28

GRDX-$3.25

ROE (TTM)

ALGS-16072.0%

GRDX-5679.0%

ROA (TTM)

ALGS-9230.0%

GRDX-3050.0%

ROIC (TTM)

ALGS-16035.0%

GRDX-5425.0%

Cash

ALGS$30M

GRDX$1M

Debt

ALGS$64K

GRDX$2M

Net Cash/Debt

ALGS$30M

GRDX$-297K

Current Ratio (TTM)

ALGS2.19x

GRDX0.16x

Quick Ratio (TTM)

ALGS2.19x

GRDX0.13x

Debt/Equity (TTM)

ALGS0.00x

GRDX0.12x

Debt/Assets (TTM)

ALGS0.0%

GRDX0.0%

Interest Coverage (TTM)

ALGSN/A

GRDXN/A

Net Debt/EBITDA (TTM)

ALGS0.00x

GRDX0.00x

Beta

ALGS2.48

GRDX1.72

52W Performance

ALGS-46.2%

GRDX24.2%

YTD Performance

ALGS-41.5%

GRDX-3.3%

% from 52W High

ALGS-61.0%

GRDX-28.3%

% from 52W Low

ALGS34.2%

GRDX165.8%

Asset Turnover (TTM)

ALGS0.38x

GRDX0.00x

FCF Yield (TTM)

ALGS-286.0%

GRDX-24.2%

Earnings Yield (TTM)

ALGS-229.8%

GRDX-62.0%

Dividend Yield (TTM)

ALGSN/A

GRDXN/A

Rule of 40

ALGS593.1

GRDX-5,062.9

EV/GP/RG

ALGSN/A

GRDXN/A

Ticker research

View ALGS research View GRDX research

Metric	ALGS Aligos Therapeutics Inc	GRDX GridAI Technologies Corp
Market & Valuation
Market Cap	$33M	$34M
Enterprise Value	$3M	$34M
Price	$5.34	$4.97
P/E Ratio	N/A	N/A
P/S Ratio	1.05x	209.46x
EV/Sales	0.09x	211.31x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.09x	1.94x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.03x	-4.17x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.83x	N/A
Revenue & Growth
Revenue (TTM)	$32M	$160K
Revenue Growth (YoY)	893.0%	N/A
Forward Rev Growth	-84.9%	0.0%
Profitability
Gross Margin (TTM)	0.0%	-815.2%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-247.2%	-6577.4%
Net Margin (TTM)	-241.0%	-12994.7%
FCF Margin (TTM)	-299.9%	-5062.9%
Net Income (TTM)	$-76M	$-21M
FCF (TTM)	$-95M	$-8M
EPS (TTM)	-$7.28	-$3.25
ROE (TTM)	-16072.0%	-5679.0%
ROA (TTM)	-9230.0%	-3050.0%
ROIC (TTM)	-16035.0%	-5425.0%
Financial Health
Cash	$30M	$1M
Debt	$64K	$2M
Net Cash/Debt	$30M	$-297K
Current Ratio (TTM)	2.19x	0.16x
Quick Ratio (TTM)	2.19x	0.13x
Debt/Equity (TTM)	0.00x	0.12x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.48	1.72
52W Performance	-46.2%	24.2%
YTD Performance	-41.5%	-3.3%
% from 52W High	-61.0%	-28.3%
% from 52W Low	34.2%	165.8%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.00x
FCF Yield (TTM)	-286.0%	-24.2%
Earnings Yield (TTM)	-229.8%	-62.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	593.1	-5,062.9
EV/GP/RG	N/A	N/A
Ticker research	View ALGS research	View GRDX research

Valuation

P/S Ratio

ALGS

1.05x

GRDX

209.46x

EV/FCF

GRDX

-4.17x

ALGS

-0.03x

Growth & revenue

Revenue Growth TTM

ALGS

893.0%

Forward Revenue Growth

GRDX

0.0%

ALGS

-84.9%

Profitability & performance

Gross Margin

ALGS

0.0%

GRDX

-815.2%

ROE

GRDX

-5679.0%

ALGS

-16072.0%

FCF Yield %

GRDX

-24.2%

ALGS

-286.0%

52-Week Performance

GRDX

24.2%

ALGS

-46.2%

Detailed metrics comparison

ALGS

Aligos Therapeutics Inc

GRDX

GridAI Technologies Corp

Market Cap

ALGS$33M

GRDX$34M

Enterprise Value

ALGS$3M

GRDX$34M

Price

ALGS$5.34

GRDX$4.97

P/E Ratio

ALGSN/A

GRDXN/A

P/S Ratio

ALGS1.05x

GRDX209.46x

EV/Sales

ALGS0.09x

GRDX211.31x

EV/EBITDA

ALGS0.00x

GRDX0.00x

P/B Ratio

ALGS1.09x

GRDX1.94x

P/FCF Ratio

ALGSN/A

GRDXN/A

EV/FCF

ALGS-0.03x

GRDX-4.17x

PEG Ratio

ALGSN/A

GRDXN/A

Forward P/E (NTM)

ALGSN/A

GRDXN/A

Forward P/S (NTM)

ALGS4.83x

GRDXN/A

Revenue (TTM)

ALGS$32M

GRDX$160K

Revenue Growth (YoY)

ALGS893.0%

GRDXN/A

Forward Rev Growth

ALGS-84.9%

GRDX0.0%

Gross Margin (TTM)

ALGS0.0%

GRDX-815.2%

Operating Margin (TTM)

ALGS0.0%

GRDX0.0%

EBITDA Margin (TTM)

ALGS-247.2%

GRDX-6577.4%

Net Margin (TTM)

ALGS-241.0%

GRDX-12994.7%

FCF Margin (TTM)

ALGS-299.9%

GRDX-5062.9%

Net Income (TTM)

ALGS$-76M

GRDX$-21M

FCF (TTM)

ALGS$-95M

GRDX$-8M

EPS (TTM)

ALGS-$7.28

GRDX-$3.25

ROE (TTM)

ALGS-16072.0%

GRDX-5679.0%

ROA (TTM)

ALGS-9230.0%

GRDX-3050.0%

ROIC (TTM)

ALGS-16035.0%

GRDX-5425.0%

Cash

ALGS$30M

GRDX$1M

Debt

ALGS$64K

GRDX$2M

Net Cash/Debt

ALGS$30M

GRDX$-297K

Current Ratio (TTM)

ALGS2.19x

GRDX0.16x

Quick Ratio (TTM)

ALGS2.19x

GRDX0.13x

Debt/Equity (TTM)

ALGS0.00x

GRDX0.12x

Debt/Assets (TTM)

ALGS0.0%

GRDX0.0%

Interest Coverage (TTM)

ALGSN/A

GRDXN/A

Net Debt/EBITDA (TTM)

ALGS0.00x

GRDX0.00x

Beta

ALGS2.48

GRDX1.72

52W Performance

ALGS-46.2%

GRDX24.2%

YTD Performance

ALGS-41.5%

GRDX-3.3%

% from 52W High

ALGS-61.0%

GRDX-28.3%

% from 52W Low

ALGS34.2%

GRDX165.8%

Asset Turnover (TTM)

ALGS0.38x

GRDX0.00x

FCF Yield (TTM)

ALGS-286.0%

GRDX-24.2%

Earnings Yield (TTM)

ALGS-229.8%

GRDX-62.0%

Dividend Yield (TTM)

ALGSN/A

GRDXN/A

Rule of 40

ALGS593.1

GRDX-5,062.9

EV/GP/RG

ALGSN/A

GRDXN/A

Ticker research

View ALGS research View GRDX research

Metric	ALGS Aligos Therapeutics Inc	GRDX GridAI Technologies Corp
Market & Valuation
Market Cap	$33M	$34M
Enterprise Value	$3M	$34M
Price	$5.34	$4.97
P/E Ratio	N/A	N/A
P/S Ratio	1.05x	209.46x
EV/Sales	0.09x	211.31x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.09x	1.94x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.03x	-4.17x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.83x	N/A
Revenue & Growth
Revenue (TTM)	$32M	$160K
Revenue Growth (YoY)	893.0%	N/A
Forward Rev Growth	-84.9%	0.0%
Profitability
Gross Margin (TTM)	0.0%	-815.2%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-247.2%	-6577.4%
Net Margin (TTM)	-241.0%	-12994.7%
FCF Margin (TTM)	-299.9%	-5062.9%
Net Income (TTM)	$-76M	$-21M
FCF (TTM)	$-95M	$-8M
EPS (TTM)	-$7.28	-$3.25
ROE (TTM)	-16072.0%	-5679.0%
ROA (TTM)	-9230.0%	-3050.0%
ROIC (TTM)	-16035.0%	-5425.0%
Financial Health
Cash	$30M	$1M
Debt	$64K	$2M
Net Cash/Debt	$30M	$-297K
Current Ratio (TTM)	2.19x	0.16x
Quick Ratio (TTM)	2.19x	0.13x
Debt/Equity (TTM)	0.00x	0.12x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.48	1.72
52W Performance	-46.2%	24.2%
YTD Performance	-41.5%	-3.3%
% from 52W High	-61.0%	-28.3%
% from 52W Low	34.2%	165.8%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.00x
FCF Yield (TTM)	-286.0%	-24.2%
Earnings Yield (TTM)	-229.8%	-62.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	593.1	-5,062.9
EV/GP/RG	N/A	N/A
Ticker research	View ALGS research	View GRDX research